Selexis SA has made key strategic hires, signed its one hundredth commercial license agreement (CLA), and purchased and installed $2 million in new laboratory equipment following its acquisition by JSR Corporation in June 2017.    The new employees are to be based in Geneva, the U.S., and Tokyo, in the areas of whole genome sequencing, global business development, production and operations. The state-of-the-art laboratory equipment will be housed at the company’s laboratory facility and ...